BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1006 related articles for article (PubMed ID: 16111471)

  • 1. Preoperative and adjuvant therapies for upper gastrointestinal cancers.
    Varadhachary G; Ajani JA
    Expert Rev Anticancer Ther; 2005 Aug; 5(4):719-25. PubMed ID: 16111471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoadjuvant treatment in upper gastrointestinal adenocarcinomas: new paradigms from old concepts?
    Samalin E; Ychou M
    Curr Opin Oncol; 2007 Jul; 19(4):384-9. PubMed ID: 17545805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer of the gastroesophageal junction: combined modality therapy.
    Ilson DH
    Surg Oncol Clin N Am; 2006 Oct; 15(4):803-24. PubMed ID: 17030275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant and neoadjuvant therapy for gastric cancer.
    Kelsen DP
    Semin Oncol; 1996 Jun; 23(3):379-89. PubMed ID: 8658222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative concurrent chemotherapy and radiation therapy followed by surgery for esophageal cancer.
    Yano M; Inoue M; Shiozaki H
    Ann Thorac Cardiovasc Surg; 2002 Jun; 8(3):123-30. PubMed ID: 12472392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Esophageal cancer: adjuvant therapy.
    Ku GY; Ilson DH
    Cancer J; 2007; 13(3):162-7. PubMed ID: 17620765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Individualized surgical strategies for cancer of the esophagogastric junction.
    Stein HJ; Feith M; Siewert JR
    Ann Chir Gynaecol; 2000; 89(3):191-8. PubMed ID: 11079787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative therapy in esophageal cancer.
    Ku GY; Ilson DH
    Clin Adv Hematol Oncol; 2008 May; 6(5):371-9. PubMed ID: 18516027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Utilization of multimodal therapy concepts in stomach carcinoma in Germany].
    Bösing NM; Heise JW; Röher HD
    Zentralbl Chir; 2000; 125(4):341-7. PubMed ID: 10829314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant chemoradiotherapy in gastric cancer and carcinoma of the oesophago-gastric junction.
    Stahl M
    Onkologie; 2004 Feb; 27(1):33-6. PubMed ID: 15007246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Value of radiotherapy and chemotherapy in treatment of operable cancers of the esophagus].
    Msika S; Hay JM
    J Chir (Paris); 2002 Feb; 139(1):17-24. PubMed ID: 12071024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy of current adjuvant and neoadjuvant therapeutic concepts in gastric cancer?].
    Kretzschmar A; Schlag PM
    Zentralbl Chir; 2006 Apr; 131(2):121-5. PubMed ID: 16612778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathologic nodal status predicts disease-free survival after neoadjuvant chemoradiation for gastroesophageal junction carcinoma.
    Gaca JG; Petersen RP; Peterson BL; Harpole DH; D'Amico TA; Pappas TN; Seigler HF; Wolfe WG; Tyler DS
    Ann Surg Oncol; 2006 Mar; 13(3):340-6. PubMed ID: 16485154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Resectable adenocarcinoma of the oesophagogastric junction care: which perioperative treatment?].
    Créhange G; Bonnetain F; Chauffert B; Rat P; Bedenne L; Maingon P
    Cancer Radiother; 2008 Sep; 12(5):365-73. PubMed ID: 18420440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant therapy in gastric cancer.
    Lim L; Michael M; Mann GB; Leong T
    J Clin Oncol; 2005 Sep; 23(25):6220-32. PubMed ID: 16135489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The number of lymph nodes with metastasis predicts survival in patients with esophageal or esophagogastric junction adenocarcinoma who receive preoperative chemoradiation.
    Gu Y; Swisher SG; Ajani JA; Correa AM; Hofstetter WL; Liao Z; Komaki RR; Rashid A; Hamilton SR; Wu TT
    Cancer; 2006 Mar; 106(5):1017-25. PubMed ID: 16456809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study protocol of a randomized phase III trial of comparing preoperative chemoradiation with preoperative chemotherapy in patients with locally advanced gastric cancer or esophagogastric junction adenocarcinoma: PREACT.
    Liu X; Jin J; Cai H; Huang H; Zhao G; Zhou Y; Wu J; Du C; Long Z; Fang Y; Ma M; Li G; Zhou M; Yin J; Zhu X; Zhu J; Sheng W; Huang D; Zhu H; Zhang Z; Lu Q; Xie L; Zhang Z; Wang Y
    BMC Cancer; 2019 Jun; 19(1):606. PubMed ID: 31221115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selecting a specific pre- or postoperative adjuvant therapy for individual patients with operable gastric cancer.
    Briasoulis E; Liakakos T; Dova L; Fatouros M; Tsekeris P; Roukos DH; Kappas AM
    Expert Rev Anticancer Ther; 2006 Jun; 6(6):931-9. PubMed ID: 16761937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of irradiation as a component of combined modality treatment for gastric cancer.
    Gunderson LL; Burch PA; Donohue JH
    J Infus Chemother; 1995; 5(3):117-24. PubMed ID: 8528968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative therapy for esophageal cancer.
    Ku GY; Ilson DH
    Gastroenterol Clin North Am; 2009 Mar; 38(1):135-52, ix. PubMed ID: 19327572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.